Chemveda Life Sciences

Chemveda Life Sciences is a mid-sized, rapid-growing solution provider to the pharmaceutical, biotech, academia, and agrochemical industries. As a contract research partner Chemveda is boosting its value creation along and beyond the drug discovery & development continuum with a strong focus on churning out cost and timeline efficiencies for its global clientele. Chemveda harnesses its command over science and technology to deliver full suite Chemistry support spanning from lab scale synthesis, till industrial Process R&D, and large-scale custom development of drug substances, key intermediates, and starting materials. Lately, we have been invested in developing in-house capabilities on the most sought-after scientific platforms to answer the existing and evolving challenges in the field of basic and applied research. Founded and headquartered in 2008 in Hyderabad, Chemveda is over 350 employees strong with a technology-based division of teams. We have our US presence through our office in San Diego and also a team of same-time zone project managers & consultants deployed across the major biotech hubs of US, Europe, and Asia. Chemveda witnessed steady growth until 2016, which marked as a turning point with a change of hands, and a more conducive decision making and cash-flow. The first step soon after this change was to strengthen the scientific core which started with Prof. Nicolaou being inducted as a mentor which has now grown to the likes of Prof. Phil S Baran, Prof. Jin Quan Yu, Prof. Scott Snyder, Prof. David Yu-Kai Chen, and Prof. David Sarlah. This proved to be the most instrumental step in creating a team of self-sustained thought leaders and support system and is still continuing to be so. Being solely a service provider all our offerings are based on a strong foundation for safeguarding the clients IP and zero-conflict mix of investors, none of whom come from the allied industry. Strong focus on people has always been a core to our expansion and we have empowered them with the latest infrastructure, systems and processes, and desired equipment ratio which is either on par or better than the industry standard. We have completed two stages of expansion and set for third stage at this moment. As we achieve the milestones of growth we wish to grow not only in terms of our scientific capabilities and human talent, but also by generating qualitative as well as quantitative value for our clients as well as shareholders. For more information, please visit us at: http://chemvedals.com/;